Y
Yseop
AI · New York City, United States · Founded 2008
AI software company that turns data into written insight in real time MoreLess
Yseop is an enterprise software company that specializes in artificial intelligence, with a focus on Natural Language Generation (NLG) for regulated industries. The company primarily serves the life sciences and pharmaceutical sectors.
Yseop provides a no-code, AI-powered platform designed to automate the creation of complex and regulated documentation. This platform functions as a "Copilot" for medical writers and other professionals, streamlining the process of generating reports for clinical trials and other regulatory submissions. The technology is built to ensure accuracy and compliance, significantly accelerating workflows from the initial draft to the final submission.
The business model is centered on providing its software platform to enterprises (B2B). By automating report generation, Yseop enables its clients to enhance productivity and reduce the time and resources spent on documentation. The company was founded in 2000 and has offices in Europe and the Americas, including Paris, New York, Lyon, and Bogota.
Keywords: NLG, Generative AI, Report Automation, Life Sciences, Pharmaceutical, Regulatory Compliance, Medical Writing, No-Code Platform, Clinical Trials, Data Analysis
Talent graph
Yseop's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Yseop's cap table
Sourced from Dealroom's funding and investor records.






Global footprint
Where Yseop has talent and traffic
team presence
Market sentiment
What the market is saying about Yseop
An AI-synthesized read of the highest-engagement posts about Yseop on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yseop on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.